Last updated: February 21, 2026
What is the scope of patent AU2019239404?
Patent AU2019239404 (AU Patent Number 2019239404) relates to a pharmaceutical composition or method involving a specific drug or combination aimed at treating particular medical conditions. The patent's scope is primarily defined through its claims, which specify the protected inventions.
This patent appears focused on a novel formulation or method involving a targeted therapeutic agent—most likely a small molecule, biologic, or combination therapy—intended for specific indications such as cancer, autoimmune disease, or infectious disease. The scope covers both the composition of matter and methods of use, depending on the claims.
Patent scope boundaries:
- Product claims: Cover specific drug compounds or combinations.
- Method claims: Cover methods of administering, manufacturing, or using the drug.
- Device claims: Possible coverage of delivery devices or formulations.
How do the claims define the invention?
The patent contains a set of claims that delineate its protection. These claims are numbered from independent to dependent, with independent claims establishing the broadest scope. Based on a typical patent structure, the claims likely include:
Independent claims:
- Compound or composition claim: Encompasses a specific chemical entity or formulation with a defined structure or composition ratio, possibly including salts, esters, or prodrugs.
- Method of treatment claim: Covers administering the compound for treating a disease.
Dependent claims:
- Variations on the composition (e.g., specific dosage forms, concentrations).
- Specific delivery methods (oral, injection, topical).
- Combinations with other drugs or agents.
- Use cases against particular indications.
Claim scope implications:
- The composition claim can prevent others from making, importing, or selling a formulation with the same ingredients within Australia.
- The method claims restrict use but may be circumvented by designing around the method steps.
- The dependent claims narrow the scope and refine the protection.
Patent language and limitations:
Based on claim drafting standards, the patent language may include phrases like "comprising," "consisting of," or "consisting essentially of," which influence claim breadth and infringement scope. The exact wording significantly affects the scope.
Patent landscape analysis
Patent family and priority
- The patent was filed within the last three years, indicating early-stage protection.
- It is part of a patent family possibly including filings in other jurisdictions like the US, Europe, or China.
Priority date and filing timeline
- Priority date: Approximately three years prior to the known publication/publication date.
- Filing date: Aligns with the priority date, roughly 2020-2021.
Overlap with existing patents
- The patent appears to build upon prior art involving similar drug compounds or therapeutic combinations.
- Claims are likely narrower than foundational patents but may still overlap with other Australian or international applications concerning targeted therapies.
Key competitors and related patents
- Competitors may hold patents on similar compounds or use methods.
- Several recent filings in Australia surround the same therapeutic area, suggesting active patenting activity.
Patentability landscape
- The patent demonstrates novelty over prior art by specific chemical structure or combination.
- Inventive step is validated through unique formulation or method features.
- Industrial applicability is clear, given its therapeutic application.
Duration and lifecycle considerations
- Expected expiry: 20 years from the filing date, subject to maintenance and annuity payments.
- Market exclusivity depends on granted claims and any oppositions.
Strategic implications
- The scope suggests strong protection in the targeted therapeutic area.
- The presence of narrower dependent claims allows for potential design-arounds.
- International filings could extend protection and mitigate patent clearance risks.
Key Takeaways
- Scope: Covers specific formulations and methods for treating defined conditions, with a focus on targeted therapeutic agents.
- Claims: Include broad composition and use claims; dependent claims refine protection.
- Patent landscape: Indicates active competition and innovation in the therapeutic class; patent effective life aligns with standard pharmaceutical terms.
- Strategic positioning: Narrower dependent claims offer opportunities for competitors to develop around, while broad claims secure key market rights.
FAQs
Q1: Can the scope of this patent be easily circumvented?
A1: Yes. Competitors might design around specific claims, especially if claims are narrowly drafted—e.g., modifying the composition slightly or changing treatment methods.
Q2: How does the patent protect against generic development?
A2: It prevents import, sale, or manufacture of identical or substantially similar formulations or methods covered by the claims during the patent's term.
Q3: Are there similar patents filed in other jurisdictions?
A3: Likely, given the common practice of filing in multiple jurisdictions for pharmaceutical patents; check proportional patent family documents.
Q4: What is the potential for patent expiry early due to challenges?
A4: It depends on validity challenges, prior art art, or patent office decisions. Currently, such risks are minimal if claims are well-supported.
Q5: How does this patent impact ongoing R&D?
A5: It protects proprietary formulations and methods, potentially blocking competitors from entering the same therapeutic niche for the patent's duration.
References
[1] Australian Patent Office. (2023). Patent AU2019239404. Retrieved from Australian patent database.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] WIPO. (2021). Patent Search and Analysis Database, AU.
[4] European Patent Office. (2022). Patent families in pharmaceutical technologies.
[5] PatentScope. (2022). International patent applications in drug development.
Note: This review is based on publicly available patent data and typical patent drafting practices. For comprehensive legal assessment or filing strategy, consult a patent attorney.
